Efficient IC Process and Anaerobic Solutions for Pharmaceutical Wastewater Treatment Projects in Vietnam

The pharmaceutical industry in Vietnam is experiencing a period of unprecedented growth. As one of the most dynamic Pharmerging markets globally, Vietnam’s pharmaceutical sector is projected to reach billions of dollars in valuation by 2026. However, this industrial expansion brings significant environmental responsibilities. Managing complex effluent is now a top priority for local manufacturers. As a premier global EPC contractor, Center Enamel specializes in delivering high-efficiency Anaerobic Solutions, particularly the Internal Circulation (IC) process, to help Vietnamese enterprises transform wastewater challenges into sustainable operational success.

The Landscape of Vietnam’s Pharmaceutical Industry and Environmental Policy

Vietnam has become a strategic hub for pharmaceutical manufacturing in Southeast Asia, driven by increasing domestic demand and a surge in foreign direct investment. However, the Vietnamese government has tightened environmental regulations, such as Decree No. 08/2022/ND-CP, which mandates stricter discharge standards and more rigorous environmental impact assessments for industrial facilities.

For pharmaceutical plants in industrial zones like those in Binh Duong or Bac Ninh, the pressure to comply with National Technical Regulations (QCVN) is high. Failure to meet these standards can result in heavy fines or operational suspensions, making advanced Pharmaceutical Wastewater Treatment Projects a necessity rather than an option.

Challenges of Pharmaceutical Wastewater in Vietnam

Pharmaceutical manufacturing produces some of the most difficult-to-treat wastewater. Unlike municipal sewage, which primarily consists of organic matter from domestic activities like kitchens and bathrooms, industrial pharmaceutical effluent is characterized by:

High Toxicity: The presence of residual active pharmaceutical ingredients (APIs), antibiotics, and solvents can be lethal to the microbial populations used in standard biological treatment.

Extreme Organic Loading: Effluents often feature exceptionally high Chemical Oxygen Demand (COD) and Biological Oxygen Demand (BOD) levels that overwhelm conventional systems.

Variable Salinity and pH: Production cycles for different medicines lead to inconsistent wastewater quality, creating "shock loads" that can destabilize traditional treatment plants.

Comprehensive Pharmaceutical Wastewater Treatment Flow

To handle these complexities, Center Enamel implements a scientifically structured, high-performance treatment flow:

Pre-treatment: Physical screening, grit removal, and pH adjustment are used to stabilize the raw effluent before it enters biological stages.

Anaerobic Core: This is the most critical stage. High-rate reactors like IC or UASB are used to break down the bulk of the high-strength organic matter into biogas.

Aerobic Polishing: Following anaerobic treatment, aerobic processes remove residual COD and nutrients through oxidation.

Advanced Filtration & Disinfection: Technologies such as membranes (MBR/RO) or activated carbon ensure the water meets the strictest QCVN discharge standards for reuse or safe release.

Core Anaerobic Technologies: IC, UASB, CSTR, and USR

Center Enamel integrates a suite of specialized anaerobic technologies tailored to the specific needs of each project:

IC (Internal Circulation) Reactor: Representing the next generation of high-rate technology, the IC reactor uses a unique two-stage anaerobic process. It circulates sludge internally, allowing it to handle significantly higher organic loads while providing superior stability against the shock loads common in pharmaceutical production.

UASB (Upflow Anaerobic Sludge Blanket): A globally recognized high-rate solution. It treats liquid-phase sewage by passing it through a dense blanket of anaerobic sludge, offering high efficiency in a compact footprint.

CSTR (Continuous Stirred Tank Reactor): This process is ideal for wastewater with high suspended solids (SS). Mechanical stirring ensures uniform contact between the waste and microorganisms, preventing sedimentation issues.

USR (Upflow Solids Reactor): Specifically engineered for effluents with very high solid content, the USR ensures that organic particles are fully digested and converted into energy.

The Advantage of Glass-Fused-to-Steel (GFS) Tanks

Center Enamel’s EPC solutions utilize proprietary Glass-Fused-to-Steel (GFS) tanks as the primary containment vessels. These tanks offer decisive benefits over traditional concrete for the Vietnamese market:

Superior Corrosion Resistance: The glass-to-steel bond is chemically inert and impervious to the aggressive organic acids and chemicals found in pharmaceutical waste.

Rapid Modular Installation: Vietnam’s rainy season can delay concrete construction. GFS tanks are bolted together quickly on-site, drastically reducing project timelines and minimizing factory downtime.

Flexibility and Longevity: With a service life of over 30 years, these tanks can be easily expanded or even relocated as a manufacturer's production capacity grows.

Why Choose Center Enamel as Your EPC Partner?

Choosing Center Enamel means partnering with a global leader that offers a seamless, turnkey experience:

Customized Engineering: We provide precision-designed systems tailored to the specific chemical footprint and effluent standards of your facility.

Proven Global Expertise: With successful projects in over 100 countries, we bring international engineering excellence to Vietnam’s local pharmaceutical sector.

Full Lifecycle Support: From initial process design and GFS tank fabrication to automated control systems and long-term commissioning, we handle every detail.

Success Stories in Pharmaceutical Wastewater Treatment

Case1: Inner Mongolia Pharmaceutical Wastewater Treatment Project

Process: UASB

Tank Dimensions: φ13.76 × 13.2 m (H) — 1 Unit

Total Tank Volume: 1,962 m³

Completion Date: 2023

Case2: Zhejiang Pharmaceutical Plant Wastewater Treatment Project

Process: IC

Tank Dimensions: φ12.66 × 24 m (H) — 6 Units

Total Tank Volume: 18,114 m³

Completion Date: 2019

As Vietnam’s pharmaceutical industry moves toward higher standards and sustainable growth, the need for advanced wastewater solutions has never been greater. Center Enamel’s integration of the IC process and Glass-Fused-to-Steel technology provides manufacturers with a future-proof foundation for environmental compliance. By selecting a professional EPC partner with specialized anaerobic expertise, Vietnamese pharmaceutical companies can protect local water resources while ensuring their long-term economic competitiveness in the global market.